{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:07:34Z","timestamp":1761743254908},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.juro.2009.06.026","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T06:28:25Z","timestamp":1251354505000},"page":"1306-1312","source":"Crossref","is-referenced-by-count":19,"title":["Fibrin Clot Inhibitor Medication and Efficacy of Bacillus Calmette-Guerin for Bladder Urothelial Cancer"],"prefix":"10.1097","volume":"182","author":[{"given":"Stephen A.","family":"Boorjian","sequence":"first","affiliation":[{"name":"Section of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan K.","family":"Berglund","sequence":"additional","affiliation":[{"name":"Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra C.","family":"Maschino","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry W.","family":"Herr","sequence":"additional","affiliation":[{"name":"Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2009.06.026_bib1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2009.06.026_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2009.06.026_bib4","first-page":"1762","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of bacillus Calmette-Gu\u00e9rin","volume":"47","author":"Ratliff","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2009.06.026_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-5347(17)42445-1","article-title":"Role of fibronectin in intravesical BCG therapy for superficial bladder cancer","volume":"139","author":"Ratliff","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI114434","article-title":"Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa","volume":"85","author":"Kavoussi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.juro.2009.06.026_bib7","first-page":"3726","article-title":"Modulation of fibronectin-mediated bacillus Calmette-Gu\u00e9rin attachment to murine bladder mucosa by drugs influencing the coagulation pathways","volume":"51","author":"Hudson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2009.06.026_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(17)39741-0","article-title":"Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors","volume":"144","author":"Hudson","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1445-2197.1993.tb00060.x","article-title":"The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Gu\u00e9rin efficacy for superficial bladder cancer","volume":"63","author":"P'ng","year":"1993","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.juro.2009.06.026_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000474631","article-title":"Influence of fibrin clot inhibitors on the efficacy of intravesical bacillus Calmette-Gu\u00e9rin in the treatment of superficial bladder cancer","volume":"23","author":"Witjes","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-410X.2008.08123.x","article-title":"Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Gu\u00e9rin","volume":"103","author":"Gee","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2009.06.026_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.1987.tb05039.x","article-title":"Local immune responses after intravesical BCG treatment for carcinoma in situ","volume":"60","author":"El-Demiry","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.juro.2007.11.045","article-title":"The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study","volume":"179","author":"Pan","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.juro.2008.06.034","article-title":"An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder","volume":"180","author":"Berglund","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.amjcard.2006.04.012","article-title":"Meta-analysis of data from six preliminary prevention trials of cardiovascular events using aspirin","volume":"98","author":"Bartolucci","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.juro.2009.06.026_bib16","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.292.15.1867","article-title":"Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease","volume":"292","author":"Tran","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2009.06.026_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5347(17)43040-0","article-title":"Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces","volume":"138","author":"See","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib18","first-page":"5414","article-title":"Pathophysiology of transitional tumor cell adherence to sites of urothelial injury in rats: mechanisms mediating intravesical recurrence due to implantation","volume":"49","author":"See","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2009.06.026_bib19","first-page":"5647","article-title":"Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder","volume":"59","author":"Mohammed","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2009.06.026_bib20","first-page":"5599","article-title":"Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats","volume":"60","author":"Grubbs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2009.06.026_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.ju.0000161589.85869.ae","article-title":"Cyclooxygenase-2 inhibition: a potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"174","author":"Dovedi","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.06.026_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1987.5.3.441","article-title":"A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Gu\u00e9rin therapy of superficial bladder cancer","volume":"5","author":"Badalament","year":"1987","journal-title":"J Clin Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709014955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709014955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.06.026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:55:15Z","timestamp":1651197315000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.06.026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1016\/j.juro.2009.06.026"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.06.026","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}